以色列军事人群中针对脂多糖的血清抗体及对志贺氏菌病的天然免疫力 - Suppr

Suppr

超能文献

Serum antibodies to lipopolysaccharide and natural immunity to shigellosis in an Israeli military population.

作者信息

Cohen D, Green M S, Block C, Rouach T, Ofek I

机构信息

Israel Defence Force, Medical Corps, Tel Aviv.

出版信息

J Infect Dis. 1988 May;157(5):1068-71. doi: 10.1093/infdis/157.5.1068.

DOI:10.1093/infdis/157.5.1068

PMID:3283258

Abstract

摘要

相似文献

Serum antibodies to lipopolysaccharide and natural immunity to shigellosis in an Israeli military population.以色列军事人群中针对脂多糖的血清抗体及对志贺氏菌病的天然免疫力

J Infect Dis. 1988 May;157(5):1068-71. doi: 10.1093/infdis/157.5.1068.

Prospective cohort studies of shigellosis during military field training.军事野外训练期间志贺氏菌病的前瞻性队列研究。

Eur J Clin Microbiol Infect Dis. 2001 Feb;20(2):123-6. doi: 10.1007/s100960000428.

Characterization and quantitative analysis of serum IgG class and subclass response to Shigella sonnei and Shigella flexneri 2a lipopolysaccharide following natural Shigella infection.自然感染志贺菌后，血清中针对宋内志贺菌和福氏志贺菌2a脂多糖的IgG类和亚类反应的特征及定量分析。

J Infect Dis. 1997 May;175(5):1128-33. doi: 10.1086/516452.

Clinical trials of Shigella vaccines in Israel.以色列志贺氏菌疫苗的临床试验。

Adv Exp Med Biol. 1996;397:159-67. doi: 10.1007/978-1-4899-1382-1_21.

Natural immunity to shigellosis in two groups with different previous risks of exposure to Shigella is only partly expressed by serum antibodies to lipopolysaccharide.

J Infect Dis. 1992 Apr;165(4):785-7. doi: 10.1093/infdis/165.4.785.

Sociodemographic factors associated with serum anti-Shigella lipopolysaccharide antibodies and shigellosis.

Int J Epidemiol. 1991 Jun;20(2):546-50. doi: 10.1093/ije/20.2.546.

Shigella lipopolysaccharide antibodies in pediatric populations.儿科人群中的志贺氏菌脂多糖抗体

Pediatr Infect Dis J. 1995 Oct;14(10):859-65. doi: 10.1097/00006454-199510000-00008.

Effect of prior infection with virulent Shigella flexneri 2a on the resistance of monkeys to subsequent infection with Shigella sonnei.先前感染强毒力福氏志贺菌2a对猴子抵抗随后感染宋内志贺菌的影响。

J Infect Dis. 1991 Sep;164(3):533-7. doi: 10.1093/infdis/164.3.533.

Prospective study of the association between serum antibodies to lipopolysaccharide O antigen and the attack rate of shigellosis.脂多糖O抗原血清抗体与志贺氏菌病发病率之间关联的前瞻性研究。

J Clin Microbiol. 1991 Feb;29(2):386-9. doi: 10.1128/jcm.29.2.386-389.1991.

Detection of antibodies to Shigella lipopolysaccharide in urine after natural Shigella infection or vaccination.自然感染志贺菌或接种疫苗后尿液中志贺菌脂多糖抗体的检测。

Clin Diagn Lab Immunol. 1996 Jul;3(4):451-5. doi: 10.1128/cdli.3.4.451-455.1996.

引用本文的文献

Protein-specific immune response elicited by the 1790GAHB GMMA-based candidate vaccine in adults with varying exposure to .基于1790GAHB通用模块化疫苗载体的候选疫苗在不同暴露水平的成年人中引发的蛋白质特异性免疫反应。

mSphere. 2025 May 27;10(5):e0105724. doi: 10.1128/msphere.01057-24. Epub 2025 Apr 16.

Role of cellular effectors in the induction and maintenance of IgA responses leading to protective immunity against enteric bacterial pathogens.细胞效应因子在诱导和维持 IgA 反应中的作用，这些反应导致对肠道细菌病原体的保护性免疫。

Front Immunol. 2024 Sep 11;15:1446072. doi: 10.3389/fimmu.2024.1446072. eCollection 2024.

Development of a Shigella conjugate vaccine targeting Shigella flexneri 6 that is immunogenic and provides protection against virulent challenge.针对福氏志贺菌 6 型的志贺氏菌结合疫苗的开发，该疫苗具有免疫原性，能提供针对强毒力挑战的保护。

Vaccine. 2024 Oct 24;42(24):126263. doi: 10.1016/j.vaccine.2024.126263. Epub 2024 Aug 31.

Determinants of immune responses predictive of protection against shigellosis in an endemic zone: a systems analysis of antibody profiles and function.预测志贺氏菌病感染保护的免疫反应决定因素：抗体谱和功能的系统分析。

Lancet Microbe. 2024 Oct;5(10):100889. doi: 10.1016/S2666-5247(24)00112-5. Epub 2024 Aug 5.

Putative correlates of protection against shigellosis assessing immunomarkers across responses to S. sonnei investigational vaccine.评估针对宋内志贺菌实验性疫苗的免疫标志物，以确定预防志贺菌病的潜在相关因素。

NPJ Vaccines. 2024 Mar 8;9(1):56. doi: 10.1038/s41541-024-00822-2.

Further characterization of -specific (memory) B cells induced in healthy volunteer recipients of SF2a-TT15, a 2a synthetic glycan-based vaccine candidate.进一步鉴定 SF2a-TT15（一种 2a 合成糖基疫苗候选物）诱导的健康志愿者受体中产生的 -特异性（记忆）B 细胞。

Front Immunol. 2023 Oct 31;14:1291664. doi: 10.3389/fimmu.2023.1291664. eCollection 2023.

Development of Shigella conjugate vaccines targeting Shigella flexneri 2a and S. flexneri 3a using a simple platform-approach conjugation by squaric acid chemistry.利用新型平台偶联技术——丁烯二酸化学法，研制针对福氏 2a 亚型和福氏 3a 亚型志贺菌的志贺菌结合疫苗。

Vaccine. 2023 Jul 31;41(34):4967-4977. doi: 10.1016/j.vaccine.2023.06.052. Epub 2023 Jul 1.

Threshold protective levels of serum IgG to Shigella lipopolysaccharide: re-analysis of Shigella vaccine trials data.血清 IgG 对志贺氏菌脂多糖的阈保护水平：志贺氏菌疫苗试验数据的重新分析。

Clin Microbiol Infect. 2023 Mar;29(3):366-371. doi: 10.1016/j.cmi.2022.10.011. Epub 2022 Oct 13.

Systems approach to define humoral correlates of immunity to Shigella.系统方法定义志贺氏菌感染的体液免疫相关性。

Cell Rep. 2022 Aug 16;40(7):111216. doi: 10.1016/j.celrep.2022.111216.

Detoxified O-Specific Polysaccharide (O-SP)-Protein Conjugates: Emerging Approach in the Vaccine Development Scene.解毒O-特异性多糖（O-SP）-蛋白质偶联物：疫苗开发领域的新兴方法。

Vaccines (Basel). 2022 Apr 24;10(5):675. doi: 10.3390/vaccines10050675.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验